SNAI1 and metastatic melanoma: Along similar lines, Adhikari et al. found that gas plasma combined with silymarin could downregulate mesenchymal markers SNAI1 and CDH2 and upregulate epithelial marker CDH1 in metastatic melanoma cells [51].